Skip to main content
Livermore
Livermore
ZHEN

D. E. Shaw & Co., Inc.

SEC CIK
0001009207
Latest filing
Aug 14, 2026

APLS holding history

Apellis Pharmaceuticals, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

APLS overviewAll 13F holders of APLSFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
17
Since Q1 2021
Holdings of APLS by D. E. Shaw & Co., Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−186,853−100.0%Sold outHolders
Q1 2026186,853$7.52M<0.1%−262,823−58.4%ReducedHolders
Q4 2025449,676$11.3M<0.1%−7,115−1.6%ReducedHolders
Q3 2025456,791$10.3M<0.1%+205,722+81.9%AddedHolders
Q2 2025251,069$4.35M<0.1%+251,069NewHolders
Q1 20250$00.0%−20,000−100.0%Sold outHolders
Q4 202420,000$638.2K<0.1%+20,000NewHolders
Q1 20240$00.0%−33,086−100.0%Sold outHolders
Q4 202333,086$1.98M<0.1%−6,387−16.2%ReducedHolders
Q3 202339,473$1.50M<0.1%−488,338−92.5%ReducedHolders
Q2 2023527,811$48.1M0.1%+114,958+27.8%AddedHolders
Q1 2023412,853$27.2M<0.1%+399,955+3,100.9%AddedHolders
Q4 202212,898$667.0K<0.1%−184,466−93.5%ReducedHolders
Q3 2022197,364$13.5M<0.1%+192,794+4,218.7%AddedHolders
Q2 20224,570$207.0K<0.1%−28,464−86.2%ReducedHolders
Q1 202233,034$1.68M<0.1%−4,856−12.8%ReducedHolders
Q4 202137,890$1.79M<0.1%−37,632−49.8%ReducedHolders
Q3 202175,522$2.49M<0.1%−169,507−69.2%ReducedHolders
Q2 2021245,029$15.5M<0.1%−91,614−27.2%ReducedHolders
Q1 2021336,643$14.4M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.